Bioventus Faces Competitive Landscape in Medical Devices

Bioventus, a North Carolina-based medical device company, competes with 27 other publicly-traded firms in the surgical and medical instruments industry.

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

Bioventus (NASDAQ:BVS) is a medical device company focused on developing and commercializing treatments that engage the body's natural healing process. While Bioventus has higher revenue than its competitors, it has lower earnings per share and trades at a higher price-to-earnings ratio, indicating it may be more expensive than other companies in the industry. The analysis compares Bioventus to its competitors across factors like net margins, return on equity, analyst recommendations, and stock volatility.

Why it matters

As a publicly-traded company, Bioventus' performance and competitive positioning within the surgical and medical instruments industry is important for investors to understand. The analysis sheds light on how Bioventus stacks up against its peers in terms of financial metrics, analyst sentiment, and market risk.

The details

Bioventus focuses on developing and commercializing treatments that engage the body's natural healing process, with a portfolio spanning pain treatments, surgical solutions, and restorative therapies. While Bioventus has higher revenue than its 27 publicly-traded competitors in the 'Surgical, Medical, And Dental Instruments And Supplies' industry, it has lower earnings per share and trades at a higher price-to-earnings ratio, suggesting it may be more expensive than other firms in the space. The analysis also found that Bioventus' competitors have higher potential upside according to analyst recommendations, and their stock prices are more volatile than Bioventus'.

  • Bioventus was founded in 2011 and is headquartered in Durham, North Carolina.

The players

Bioventus Inc.

A medical device company that focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally.

Got photos? Submit your photos here. ›

The takeaway

While Bioventus has carved out a niche in the medical devices industry with its focus on natural healing treatments, it faces stiff competition from a number of publicly-traded peers. Investors will want to closely monitor Bioventus' financial performance, analyst sentiment, and market positioning relative to its competitors as it seeks to grow its business.